Faster global financial news!
Nektar Therapeutics' Q2 operating loss widened to $42.3 million, but it holds $1.02 billion in cash reserves, sufficient to last until 2028.
Nektar Therapeutics stated during its Q2 earnings call on August 13 that its lead candidate, rezpegaldesleukin (rezpeg), is undergoing two Phase III clinical trials for autoimmune diseases. Despite the company's Q2 operating loss widening to $42.3 million, its cash reserves of $1.02 billion are expected to support operations until 2028. The company anticipates full-year R&D expenditures to be between $210 million and $230 million, with key clinical trial data expected in mid-2028 and a Biologics License Application (BLA) planned for submission in 2029. Additionally, the company faces a federal court jury trial on September 8, 2026.
No AI analysis yet. Tap the "AI Analysis" button above to generate one now.
Disclaimer: This content reflects the author's personal views only and does not constitute investment advice.
24H Trending
-
1
Morgan Stanley: US AI Infrastructure Risk Financing to Reach $33.5 Billion in 2026, Doubling from 2025, as Capital Shifts from Single Components to "AI Factory" System Integration
-
2
Solidigm, a subsidiary of South Korean company SK Hynix, may list in the U.S. with a valuation of up to $150 billion.
-
3
Morgan Stanley: Market Underestimates CATL's Resilience, Maintains "Overweight" Rating for A-shares, Target Price 500 Yuan
-
4
Ripple engineer warns of AI threat: XRP Ledger once had a vulnerability that could mint trillions of XRP out of thin air.
-
5
Bubblemaps Estimates Crypto Influencer Ethan Made $125K Through 49 Token Callouts
-
6
Korean retail investors "de-Koreafied and entered America" in Q3, selling over 5.5 trillion Korean won in Korean stocks and buying over 10 trillion Korean won in US stocks.
-
7
UK Chancellor Healey plans short-term budget giveaways
-
8
Goldman Sachs partner Wilson is bullish on U.S. stocks, but multiple institutions warn of market concentration risk.
-
9
End of the USDT "Black Box" Era? Tether Undergoes First Four Audits, $184 Billion Reserves Unveiled
-
10
LYR/LYRA Token Analysis: Project Status and Market Conditions
Markets Today
Recommended Reading
Hot Topics
Svmuu focuses on blockchain industry trends and cutting-edge cryptocurrency news, while also covering real-time market data and in-depth analysis of the Hong Kong, U.S., and foreign exchange markets. Here, you can not only access professional 24/7 news updates and accurate market data, but also utilize practical investment tools to help you capitalize on opportunities in both digital assets and traditional financial markets. Whether you are a blockchain enthusiast or an investor in Hong Kong, U.S., or foreign exchange markets, we provide efficient and timely information services to empower your investment decisions.
- User Agreement
- Privacy Policy
- Contact Us
- Business Partnerships
- Disclaimer
- Content Statement
- About Us
- Sitemap
Coming Soon!
